Further analysis indicated that L-AST treatment reduced AD-related cytokine levels (IL-1β, IL-6, IL-4, and IL-13) in lymph nodes to a greater extent than AST treatment (Supplementary Figure S1). The gene discussed is IL1B; the disease is Alzheimer disease.